Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.83 Billion INR | -20.02% |
| 2022 | 7.75 Billion INR | 303.24% |
| 2021 | 1.92 Billion INR | 0.0% |
| 2020 | - INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.63 Billion INR | 3.79% |
| 2024 Q1 | 1.57 Billion INR | -19.52% |
| 2023 Q3 | 2.04 Billion INR | 8.91% |
| 2023 FY | 6.2 Billion INR | -20.02% |
| 2023 Q4 | 1.96 Billion INR | -3.98% |
| 2023 Q2 | 1.87 Billion INR | 0.06% |
| 2023 Q1 | 1.87 Billion INR | -49.87% |
| 2022 Q3 | 169.95 Million INR | -91.31% |
| 2022 FY | 7.75 Billion INR | 303.24% |
| 2022 Q2 | 1.95 Billion INR | -47.72% |
| 2022 Q1 | 3.73 Billion INR | 65.13% |
| 2022 Q4 | 3.73 Billion INR | 2100.2% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2021 Q4 | 2.26 Billion INR | -0.0% |
| 2021 Q3 | 2.26 Billion INR | 0.0% |
| 2021 FY | 1.92 Billion INR | 0.0% |
| 2020 FY | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 78.226% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 96.23% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 53.098% |
| Granules India Limited | 16.79 Billion INR | 65.288% |
| Indoco Remedies Limited | 6.04 Billion INR | 3.476% |
| Achyut Healthcare Limited | 4.86 Million INR | -119861.983% |
| Ajanta Pharma Limited | 21.06 Billion INR | 72.316% |
| Alkem Laboratories Limited | 52.29 Billion INR | 88.85% |
| Alpa Laboratories Limited | 188.89 Million INR | -2987.086% |
| Brooks Laboratories Limited | 65.62 Million INR | -8786.547% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 6.289% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -296.204% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -57.799% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 96.436% |
| Eris Lifesciences Limited | 10.42 Billion INR | 44.073% |
| FDC Limited | 8.33 Billion INR | 30.036% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 91.59% |
| Gufic Biosciences Limited | 4.16 Billion INR | -39.918% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 5.86% |
| Ipca Laboratories Limited | 29.8 Billion INR | 80.438% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -793.571% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -2925.706% |
| Lasa Supergenerics Limited | 121.02 Million INR | -4718.105% |
| Laurus Labs Limited | 24.62 Billion INR | 76.315% |
| Lupin Limited | 123.71 Billion INR | 95.287% |
| Mankind Pharma Limited | 44.52 Billion INR | 86.902% |
| Medicamen Biotech Limited | 495.49 Million INR | -1076.874% |
| Medico Remedies Limited | 262.14 Million INR | -2124.484% |
| Megasoft Limited | 342.07 Million INR | -1604.72% |
| NATCO Pharma Limited | 25.73 Billion INR | 77.342% |
| Piramal Pharma Limited | 24.47 Billion INR | 76.17% |
| RPG Life Sciences Limited | 2.48 Billion INR | -134.851% |
| Sigachi Industries Limited | 2 Billion INR | -191.235% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 97.744% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -41.425% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -518.777% |
| Unichem Laboratories Limited | 4.86 Billion INR | -19.865% |
| Wanbury Limited | 1.73 Billion INR | -236.947% |
| Windlas Biotech Limited | 1.33 Billion INR | -335.566% |
| ZIM Laboratories Limited | 1.26 Billion INR | -360.29% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 95.343% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 1068.01% |
| Divi's Laboratories Limited | 32.44 Billion INR | 82.024% |
| Hester Biosciences Limited | 1.27 Billion INR | -357.846% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -0.864% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -274.637% |
| Bal Pharma Limited | 770.19 Million INR | -657.127% |
| Strides Pharma Science Limited | 14.38 Billion INR | 59.471% |
| Venus Remedies Limited | 2.18 Billion INR | -167.176% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -96.206% |
| Shilpa Medicare Limited | 3.54 Billion INR | -64.409% |
| Aarti Drugs Limited | 8.31 Billion INR | 29.88% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -27.3% |
| Suven Life Sciences Limited | -200.79 Million INR | 3004.103% |
| Ind-Swift Limited | 2.17 Billion INR | -168.413% |
| Valiant Laboratories Limited | -60.66 Million INR | 9712.541% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 74.311% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -577.119% |
| Themis Medicare Limited | 1.5 Billion INR | -287.748% |
| Hikal Limited | 3.14 Billion INR | -85.53% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 87.528% |
| Sequent Scientific Limited | 2.97 Billion INR | -95.766% |
| Novartis India Limited | 1.32 Billion INR | -339.472% |
| Wockhardt Limited | 16.24 Billion INR | 64.093% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 70.313% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -39896.379% |
| Neuland Laboratories Limited | 8.24 Billion INR | 29.298% |
| Morepen Laboratories Limited | 6.16 Billion INR | 5.355% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -839.818% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -728.782% |